市場調査レポート

商品コード

1593521

乳房再建の市場規模・シェア・成長分析 (製品別、処置別、種類別、エンドユーザー別、地域別)：産業予測 (2024～2031年)

Breast Reconstruction Market Size, Share, Growth Analysis, By Product (Breast Implant, Tissue Expander), By Procedure (Immediate Procedures, Delayed Procedures), By Type, By End Use, By Region - Industry Forecast 2024-2031

出版日: 2024年11月11日
発行: SkyQuest
ページ情報: 英文 155 Pages
納期: 3～5営業日

価格

PDF & Excel (Single User License)

USD 5,300 834,750円

レポートPDF・Excelを1 名様のみがご利用頂けるライセンスです。PDF・Excell内のテキスト等のコピーは可能です。PDF・Excelの印刷は可能ですが、印刷したもののご利用はPDF・Excelのご利用範囲に準拠します

PDF & Excel (Multiple User License)

USD 6,200 976,500円

レポートPDF・Excel2-5名様までがご利用頂けるライセンスです。PDF・Excel内のテキスト等のコピーは可能です。PDF・Excelの印刷は可能ですが、印刷したもののご利用はPDF・Excelのご利用範囲に準拠します。

PDF & Excel (Enterprise License)

USD 7,100 1,118,250円

レポートPDF・Excelを同一企業に所属の全世界の方にご使用頂けるライセンスです。PDF・Excel内のテキスト等のコピーは可能です。PDF・Excelの印刷は可能ですが、印刷したもののご利用はPDF・Excelのご利用範囲に準拠します。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=157.50円

全表示
概要
目次

概要

サンプル依頼リストに入れる

乳房再建の世界市場規模は2022年に約5億4,910万米ドルと評価され、2023年の5億8,640万米ドルから2031年には9億9,260万米ドルに達すると予測され、予測期間（2024～2031年）のCAGRは6.8%です。

世界の乳房再建市場は、乳がん罹患率の上昇と支援的な償還政策によって大きな成長を遂げています。技術進歩と乳房再建手術の増加により、市場の見通しは引き続き明るいです。特に、乳がんによる乳房切除後の乳房再建手術にMedicareが償還金を支給しており、またServices Australiaは外部乳房プロテーゼ償還制度のもとで乳房プロテーゼに補償金を支給しています。これらの支援策により、市場力学はさらに強化されると予想されます。主要な参入企業は、乳房再建の急増する需要に対応するため、革新的な製品を発売し、啓発プログラムを展開し、地理的範囲を拡大することで積極的に対応しています。2023年10月にThe Plastic Surgery FoundationとAmerican Society of Plastic Surgeonsが主催した乳房再建啓発デーは、乳がんと診断された女性に対する乳房再建の選択肢に関する重要な情報の普及と啓発を目的としたものです。同様に、2021年10月、Sientra, Inc.はMission Plasticoと協力し、"Reshaping Lives "を立ち上げました：これは、恵まれない女性たちに乳房切除後の乳房再建サービスを無料で提供することを目的とした慈善活動です。このような取り組みが継続されるにつれ、乳房再建市場は、患者ニーズの増加と乳がんサバイバーのためのリソースの充実により、大きな成長を遂げようとしています。

市場概要
乳房インプラント
- シリコンインプラント
- ラウンド
- アナトミカル
- 生理食塩水インプラント
- ラウンド
- アナトミカル
ティッシュエキスパンダー
- 生理食塩水式ティッシュエキスパンダー
- 空気式ティッシュエキスパンダー
無細胞性皮膚基質

乳房再建市場：処置別

市場概要
同時再建処置
遅延再建処置
再移植処置

乳房再建市場：タイプ別

市場概要
片乳房再建
両乳房

乳房再建市場：エンドユーザー別

市場概要
病院・クリニック
外来手術センター
その他

乳房再建市場：地域別

市場概要
北米
- 米国
- カナダ
欧州
- ドイツ
- スペイン
- フランス
- 英国
- イタリア
- その他欧州
アジア太平洋
- 中国
- インド
- 日本
- 韓国
- その他アジア太平洋
ラテンアメリカ
- ブラジル
- その他ラテンアメリカ
中東・アフリカ（MEA）
- 湾岸協力会議 (GCC) 諸国
- 南アフリカ
- その他中東・アフリカ

競合情勢

上位5社の比較
主要企業の市場ポジショニング（2023年）
主な市場企業が採用した戦略
市場における最近の活動
主要企業の市場シェア（2023年）

主要企業プロファイル

Johnson & Johnson (米国)
Allergan Aesthetics（AbbVie） (米国)
Ideal Implant Incorporated (米国)
Sebbin (フランス)
GC Aesthetics（アイルランド）
POLYTECH Health & Aesthetics (ドイツ)
Sientra (米国)
Integra Lifesciences (米国)
RTI Surgical Holdings (米国)
Establishment Labs S.A. (米国)
Silimed（ブラジル）
Laboratories Arion (フランス)
Guangzhou Wanhe Plastic Materials Co. Ltd. (中国)
CEREPLAS (フランス)
HansBiomed (韓国)
PMT Corporation (米国)
Shanghai Kangning Medical Device (中国)
Biodermis (米国)
Surgiform Technology, Ltd. (米国)
Motiva Implants（コスタリカ）

Product Code: SQMIG35A2947

Global Breast Reconstruction Market size was valued at around USD 549.1 Million in 2022 and is expected to rise from USD 586.4 Million in 2023 to reach a value of USD 992.6 Million by 2031, at a CAGR of 6.8% over the forecast period (2024-2031).

The Global Breast Reconstruction market is experiencing significant growth driven by the rising incidence of breast cancer and supportive reimbursement policies. With technical advancements and an increasing number of breast reconstruction surgeries, the market outlook remains positive. Notably, Medicare provides reimbursement for breast reconstruction surgeries following mastectomies due to breast cancer, while Services Australia offers compensation for breast prostheses under its external breast prosthesis reimbursement scheme. These supportive initiatives are expected to enhance market dynamics further. Major industry players are actively responding by launching innovative products, rolling out awareness programs, and expanding their geographical reach to meet the surging demand for breast reconstruction. A prime example includes the Breast Reconstruction Awareness Day initiative organized by The Plastic Surgery Foundation and The American Society of Plastic Surgeons in October 2023, which aimed to raise awareness and disseminate vital information about breast reconstruction options for women diagnosed with breast cancer. Similarly, in October 2021, Sientra, Inc. collaborated with Mission Plasticos to launch "Reshaping Lives: Full Circle," a philanthropic initiative aimed at providing free post-mastectomy breast reconstruction services for underprivileged women. As these efforts continue, the Breast Reconstruction market is poised for substantial growth, fueled by both increasing patient needs and enhanced resource availability for breast cancer survivors.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Breast Reconstruction market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Breast Reconstruction Market Segmental Analysis

Global Breast Reconstruction Market is segmented by Product, Procedure, Type, End User, and region. Based on Product, the market is segmented into Breast Implant (Silicone Implants, Saline Implants), Tissue Expander (Saline Tissue Expander, Air Tissue Expander), Acellular Dermal Matrix. Based on Procedure, the market is segmented into Immediate Procedures, Delayed Procedures, Revision Procedures. Based on Type, the market is segmented into Unilateral Breast Reconstruction, and Bilateral. Based on End User, the market is segmented into Hospitals & Clinics, Ambulatory Surgical Centers, and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & and Africa.

Driver of the Global Breast Reconstruction Market

A significant market driver for the global breast reconstruction market is the heightened focus on aesthetic outcomes following surgeries such as mastectomies. As awareness among patients of the advantages and availability of reconstructive surgery increases, so does demand. Advances in surgical techniques have made breast reconstruction more acceptable and accessible, bolstered by media campaigns and educational initiatives. The rising incidence of breast cancer further intensifies the need for such reconstructive options. Moreover, societal acceptance of cosmetic improvements fuels this growth, as patients increasingly seek not only health restoration but also enhanced physical appearance, positioning breast reconstruction as a critical component of post-cancer care.

Restraints in the Global Breast Reconstruction Market

The Global Breast Reconstruction market faces significant restraint due to the high costs associated with surgeries and advanced implants. Patients often encounter financial hurdles, as insurance coverage for reconstructive procedures is frequently limited or nonexistent, making it challenging for many to afford pre-operative consultations, surgical interventions, and post-operative care. This financial strain can lead to delayed procedures, adversely impacting market growth. Furthermore, regional economic disparities exacerbate access issues, restricting availability for lower-income populations and limiting the market's potential to expand into diverse socio-economic segments. Hence, the financial landscape serves as a formidable barrier to wider market penetration.

Market Trends of the Global Breast Reconstruction Market

The Global Breast Reconstruction market is witnessing a significant shift towards less invasive techniques, driven by advancements in surgical technologies and growing patient preferences for procedures that minimize recovery time and scarring. Techniques such as autologous fat grafting and endoscopic-assisted breast reconstruction are increasingly gaining popularity due to their aesthetic advantages, reduced post-operative discomfort, and quicker rehabilitation, enhancing overall patient satisfaction. As technology continues to evolve, these minimally invasive approaches are poised to reshape the future landscape of breast reconstruction, leading to improved outcomes and broader acceptance among both patients and healthcare professionals, ultimately pushing market growth.

Introduction

Objectives of the Study
Definitions
Market Scope

Research Methodology

Information Procurement
Secondary & Primary Data Sources
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Market Overview Outlook
Supply Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges
Porters Analysis
- Competitive rivalry
- Threat of Substitute Products
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers

Key Market Insights

Key Success Factor
Degree of Competition
Top Investment Pockets
Innovation Matrix
Ecosystem of the Market
Regulatory Landscape
Technology Analysis
Patent Analysis
PESTEL Analysis
Market Attractiveness Index, 2023

Breast Reconstruction Market, By Product

Market Overview
Breast Implant
- Silicone Implants
- Round
- Anatomical
- Saline Implants
- Round
- Anatomical
Tissue Expander
- Saline Tissue Expander
- Air Tissue Expander
Acellular Dermal Matrix

Breast Reconstruction Market, By Procedure

Market Overview
Immediate Procedures
Delayed Procedures
Revision Procedures

Breast Reconstruction Market, By Type

Market Overview
Unilateral Breast Reconstruction
Bilateral

Breast Reconstruction Market, By End User

Market Overview
Hospitals & Clinics
Ambulatory Surgical Centers
Others

Breast Reconstruction Market Size by Region

Market Overview
North America
- USA
- Canada
Europe
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America
- Brazil
- Rest of Latin America
Middle East & Africa (MEA)
- GCC Countries
- South Africa
- Rest of MEA

Competitive Landscape

Top 5 Player Comparison
Market Positioning of Key Players, 2023
Strategies Adopted by Key Market Players
Recent Activities in the Market
Key Companies Market Share (%), 2023

Key Company Profiles

Johnson & Johnson (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Allergan Aesthetics (AbbVie) (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Ideal Implant Incorporated (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Sebbin (France)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
GC Aesthetics (Ireland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
POLYTECH Health & Aesthetics (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Sientra (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Integra Lifesciences (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
RTI Surgical Holdings (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Establishment Labs S.A. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Silimed (Brazil)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Laboratories Arion (France)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Guangzhou Wanhe Plastic Materials Co. Ltd. (China)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
CEREPLAS (France)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
HansBiomed (South Korea)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
PMT Corporation (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Shanghai Kangning Medical Device (China)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Biodermis (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Surgiform Technology, Ltd. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Motiva Implants (Costa Rica)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments